Browsed by
Author: André Porter

Trump administration releases its FY19 budget ?>

Trump administration releases its FY19 budget

Today, the Trump administration released the president’s budget request for fiscal 2019.  As could be expected, the administration proposed heavy cuts to agencies that support the research enterprise.   Under the president’s proposal, the National Institutes of Health and the National Science Foundation’s research and related activities accounts would have seen reductions to $24 billion and $4.2 billion, respectively. The president’s budget, however, was drafted prior to the Bipartisan Budget Act of 2018  being signed into law last week.  Consequently, his…

Read More Read More

Where we’ve been: attending the February NINDS advisory council meeting ?>

Where we’ve been: attending the February NINDS advisory council meeting

  The National Institute of Neurological Diseases and Stroke held its advisory council meeting on Feb. 1. NINDS Director Walter Koroshetz provided institute updates and a primer for an extended discussion on the Next Generation of Researchers Initiative scheduled for the advisory council meeting in May. Institute program directors proposed funding opportunities to facilitate new methods of training basic researchers with translational focuses, increasing diversity at the professoriate level, as well as revisions to the institute’s special council review policy….

Read More Read More

Apply for the ASBMB Student/Postdoc Capitol Hill Day ?>

Apply for the ASBMB Student/Postdoc Capitol Hill Day

  The American Society for Biochemistry and Molecular Biology is now accepting applications for our annual Student/Postdoc Capitol Hill Day! Every year, the ASBMB brings trainees from across the country to meet with their congressional leaders in Washington, D.C. This fully funded opportunity gives trainees the chance to help promote scientific research by directly interacting with policymakers. The deadline to apply is Feb. 26. The event will be April 11–13. Arriving on Wednesday, April 11, participants will take part in…

Read More Read More

Where we’ve been: attending the January 2018 NIGMS advisory council meeting ?>

Where we’ve been: attending the January 2018 NIGMS advisory council meeting

  The first National Institute of General Medical Sciences advisory council meeting of 2018 was convened on Jan. 18-19, with an open session on Jan. 19.  Jon Lorsch, director of the NIGMS, provided an update on the institute’s reorganization and the National Institutes of Health’s data science strategic plan. The director’s report was followed by presentations from the Federation of American Societies for Experimental Biology on its newly released report on Maximizing Shared Research Resource and James Onken on the…

Read More Read More

ASBMB statement on government shutdown ?>

ASBMB statement on government shutdown

  Update 1/22/2018: The Senate has passed a continuing resolution bill to reopen the federal government with a vote of 81-18 which is set to expire on Feb. 8.  The House of Representatives is expected to pass the measure later today.   The following statement is from Benjamin Corb, public affairs director for the American Society for Biochemistry and Molecular Biology: The American Society for Biochemistry and Molecular Biology calls on Congress and President Donald Trump to end the partisan battles…

Read More Read More

Where we’ve been: Attending the fall NIH advisory committee to the director meeting ?>

Where we’ve been: Attending the fall NIH advisory committee to the director meeting

  The National Institutes of Health’s Advisory Committee to the Director met last week to provide updates on the NIH’s activities to increase diversity, efforts to ensure scientific rigor, implementation of the 21st Century Cures Act, efforts to support the next generation of researchers, and efforts to optimize administration at the agency. The American Society for Biochemistry and Molecular Biology provided written comments to the committee prior to the commencement of the ACD convening. The ASBMB urged the NIH to…

Read More Read More

Where we’ve been: Attending the Fall NSF MPS Advisory Committee Meeting ?>

Where we’ve been: Attending the Fall NSF MPS Advisory Committee Meeting

  The National Science Foundation’s Directorate for Mathematical and Physical Sciences advisory committee met last month to go over division updates and to strategize on how to effectively partner with outside organizations.  During the first day, Jim Ulvestad, acting assistant director, provided the committee with directorate updates.  The second half of the meeting covered external partnerships, with representatives from the NSF’s other six research directorates providing feedback and lessons learned. We learned that Anne Kinney, chief scientist at the W.M….

Read More Read More

For members, by members ?>

For members, by members

  In the October issue of ASBMB Today, Rick Page, a member of the American Society for Biochemistry and Molecular Biology’s Public Affairs Advisory Committee, provided an overview of the PAACs meetings with leaders at the National Institutes of Health and the National Science Foundation in the spring. View the article here. Below are additional highlights from the agency meetings. National Institute of General Medical Sciences Update on the R35 Maximizing Investigators’ Research Award program NIGMS officials expect to reach…

Read More Read More

‘Pipettes and Politics’ episode 2 ?>

‘Pipettes and Politics’ episode 2

  The American Society for Biochemistry and Molecular Biology’s science policy podcast, “Pipettes and Politics,” has released its second episode.  In this installment, we cover updates on the controversial Tax Cuts and Jobs Act; the retirement of U.S. Rep. Lamar Smith, R-Texas, chair of the House Science, Space and Technology Committee; and the National Institutes of Health’s request for information on developing emojis for use in scientific presentations. We’re also joined by Matt Hourihan, director of the Research and Development…

Read More Read More

The U.S. House health subcommittee receives an update on the impact of the 21st Century Cures Act ?>

The U.S. House health subcommittee receives an update on the impact of the 21st Century Cures Act

  The U.S. House Energy and Commerce Committee’s health subcommittee held a hearing this week to receive updates on the implementation of the 21st Century Cures. Francis S. Collins, director of the National Institutes of Health, and Scott Gottlieb, commissioner of the Food and Drug Administration, provided testimony and updates from their agencies. Highlights from the hearing are below. You can watch a recording here. We’re including timestamps on our highlights for your quick reference. 17:17 – U.S. Rep. Michael…

Read More Read More